Speaking to Daxko's Fitness Forward, the Thrive doctor says these products usually lack safety data, and that 'taking peptides' is too vague to mean much.
Recap by typeshit. Post by @Daxko on X.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
An investor take on Lilly's pipeline. One stat stands out: Lilly said 80% of Foundayo prescriptions went to people new to GLP-1 drugs.
A GoodRx roundup of newer weight loss medications. Only the title came through, so tap through for the full list and details.
Loading…